drugset / Trial / NCT01542307

Normobaric Oxygen (NBO) Therapy in Acute Migraine

NCT01542307 ↗

Phase 2 Completed 22 enrolled Massachusetts General Hospital
RandomizedCrossoverQuadruple-blindTreatment

Summary

This is a pilot study investigating the therapeutic potential of breathing 100% oxygen in acute migraine headache.

Timeline

Start
2012-07
Primary completion
2015-09
Completion
2015-09

Outcome

Missed primary endpoint

paper mean decrease in pain score from baseline to 30 minutes) was 1.38 ± 1.42 in oxygen-treated and 1.22 ± 1.61 in air-treated attacks ( p = 0.674). PMID 27206964 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxygen Other / unclassified 100 % Inhaled

Indications